Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Cardenas-de la Garza JA, Arvizu-Rivera RI, Galarza-Delgado DA. Should patients starting biologics be screened for COVID-19? Ann Rheum Dis 2020;81:e150. [DOI: 10.1136/annrheumdis-2020-218437] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2020] [Accepted: 06/27/2020] [Indexed: 11/03/2022]

For:	Cardenas-de la Garza JA, Arvizu-Rivera RI, Galarza-Delgado DA. Should patients starting biologics be screened for COVID-19? Ann Rheum Dis 2020;81:e150. [DOI: 10.1136/annrheumdis-2020-218437] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2020] [Accepted: 06/27/2020] [Indexed: 11/03/2022]

Number

Cited by Other Article(s)

Landewé RBM, Schulze-Koops H. Response to: 'Should patients starting biologics be screened for COVID-19?' by Cardenas-de la Garza et al. Ann Rheum Dis 2020;81:e151. [PMID: 32699038 DOI: 10.1136/annrheumdis-2020-218470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2020] [Accepted: 07/10/2020] [Indexed: 11/03/2022]